title: Fallopian tube correlates of ovarian serous borderline tumors.
abstract: Ovarian serous borderline tumors (SBTs) are presumed to originate in the ovarian cortex or peritoneal surface. The pathogenetic role of the fallopian tube (FT) is unclear; however, recently, secretory cell outgrowths (SCOUTs) lacking PAX2 expression were described in benign FTs. This study addressed (1) the differentiation characteristics of SBTs and (2) the frequency of SCOUTs lacking PAX2 expression in the FTs of patients with SBTs and compared (3) SCOUT morphology and (4) PAX2 expression with SBTs. SBTs and FT epithelium shared both ciliated (p73) and secretory (HMFG2) differentiation. PAX2-null SCOUT frequency in FT cross-sections from patients with SBTs was 0.28 (110 of 398) versus 0.112 in benign hysterectomies and nearly 0 in pediatric and postpartum sterilization specimens (P = < 0.001). When adjusted for age, the differences narrowed but remained significant (P = 0.010). SCOUTs were heterogeneous, some displaying ciliated differentiation and papillary architecture. Two cases of discrete multifocal papillary SCOUTs in the FTs were associated with SBTs. All SBTs had heterogeneous PAX2 staining with areas of PAX2 loss. This study shows for the first time that PAX2-null SCOUTs are more common in the oviducts of women with SBTs and that loss of PAX2 expression occurs in most SBTs. These discoveries link both morphologic and functional gene (PAX2) alterations in the oviduct to SBTs, similar to that reported in high-grade serous carcinoma. Further study is warranted to clarify the relationship of the oviduct to serous neoplasia.
authors.affiliation: Division of Women's and Perinatal Pathology, Department of Pathology, Brigham and Women's Hospital, Boston, MA 02115, USA.
authors.forename: Anna R
authors.initials: AR
authors.lastname: Laury
authors.forename: Gang
authors.initials: G
authors.lastname: Ning
authors.forename: Charles M
authors.initials: CM
authors.lastname: Quick
authors.forename: Jonathan
authors.initials: J
authors.lastname: Bijron
authors.forename: Mana M
authors.initials: MM
authors.lastname: Parast
authors.forename: Rebeca A
authors.initials: RA
authors.lastname: Betensky
authors.forename: Sara O
authors.initials: SO
authors.lastname: Vargas
authors.forename: Frank D
authors.initials: FD
authors.lastname: McKeon
authors.forename: Wa
authors.initials: W
authors.lastname: Xian
authors.forename: Marisa R
authors.initials: MR
authors.lastname: Nucci
authors.forename: Christopher P
authors.initials: CP
authors.lastname: Crum
mesh_terms: D000328:Adult; D002648:Child; D018284:Cystadenocarcinoma, Serous / Q000235:genetics / Q000378:metabolism / Q000473:pathology*; D005185:Fallopian Tube Neoplasms / Q000235:genetics / Q000378:metabolism / Q000473:pathology*; D005260:Female; D006801:Humans; D007150:Immunohistochemistry; D010051:Ovarian Neoplasms / Q000235:genetics / Q000378:metabolism / Q000473:pathology*; D051762:PAX2 Transcription Factor / Q000096:biosynthesis / Q000235:genetics
chemical_list: D051762:PAX2 Transcription Factor; C497318:PAX2 protein, human
references.citation: J Pathol. 2010 Jan;220(1):17-23
references.pmid: 19834951
references.citation: Int J Gynecol Pathol. 2011 Jan;30(1):12-21
references.pmid: 21131839
references.citation: Ital J Anat Embryol. 2001;106(2 Suppl 2):263-76
references.pmid: 11732586
references.citation: Am J Surg Pathol. 2007 Feb;31(2):161-9
references.pmid: 17255760
references.citation: Mod Pathol. 2007 Aug;20(8):856-63
references.pmid: 17529925
references.citation: Nature. 2000 Mar 2;404(6773):99-103
references.pmid: 10716451
references.citation: Mol Oncol. 2009 Apr;3(2):97-137
references.pmid: 19383374
references.citation: Future Oncol. 2010 Jun;6(6):1003-14
references.pmid: 20528237
references.citation: J Pathol. 2010 Sep;222(1):110-6
references.pmid: 20597068
references.citation: Am J Surg Pathol. 2001 Oct;25(10):1283-9
references.pmid: 11688463
references.citation: J Pathol. 2007 Jan;211(1):26-35
references.pmid: 17117391
references.citation: J Cell Biochem Suppl. 1995;23:208-18
references.pmid: 8747398
references.citation: J Pathol. 2001 Nov;195(4):451-6
references.pmid: 11745677
references.citation: Mod Pathol. 2010 Oct;23(10):1316-24
references.pmid: 20562848
references.citation: Histopathology. 2001 Feb;38(2):87-95
references.pmid: 11207821
references.citation: Am J Surg Pathol. 2010 Mar;34(3):433-43
references.pmid: 20154587
references.citation: J Pathol. 2006 Dec;210(4):405-11
references.pmid: 17096315
references.citation: Int J Gynecol Pathol. 1990;9(4):382-3
references.pmid: 2246095
references.citation: Hum Reprod. 1998 Nov;13(11):3114-20
references.pmid: 9853867
references.citation: J Surg Oncol. 1976;8(1):61-6
references.pmid: 1249942
references.citation: Hum Pathol. 1991 Mar;22(3):287-94
references.pmid: 1706308
references.citation: Clin Cancer Res. 2005 Sep 1;11(17):6116-26
references.pmid: 16144910
references.citation: Cancer. 2010 Nov 15;116(22):5261-71
references.pmid: 20665887
references.citation: Eur J Histochem. 2007 Apr-Jun;51(2):95-102
references.pmid: 17664159
references.citation: Hematol Oncol Clin North Am. 2010 Oct;24(5):885-906
references.pmid: 20816579